Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
The popular chatbot has become a symbol of the promises, perils, and potential profits of artificial intelligence Nathan Reiff has been writing expert articles and news about financial topics such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results